tirzepatide phase 3 trial 80 weeks weight change Adults with obesity using maintain 'remarkable' loss at 88 Alternative dosing regimens of GLP-1

Studies show that inulin can contribute to a lower glycemic and insulinemic response, which is linked to improved satietymeaning people often feel satisfied sooner and stay satisfied longer

The ADA now recommends GLP1 RAs with proven benefit to slow CKD progression and reduce CV risk in people with type 2 diabetes

A new MDL has been created for GLP-1 drug vision loss claims related to Ozempic and similar medications

GLP-1 use is rebalancing entire shopping baskets

Headaches aren't a documented side effect of Ozempic, but dehydration and low blood sugar from other side effects can trigger them

- - - A new Oxford meta-analysis (P04.009, EASO 2025) confirms what many clinicians have observed: stopping GLP-1 receptor agonists often leads to rapid and near-complete weight regain within 12 years